Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 3Myeloid 2Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Genitourinary 1Classical hematology 1CNS 1Breast 1

Conditions

Myelodysplastic Syndromes 2Thrombocytopenia 1Prostatic Neoplasms 1Precancerous Conditions 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Leukemia, Myelomonocytic, Chronic 1Fanconi Anemia 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1Anemia 1

Interventions

Cyclophosphamide 20fludarabine phosphate 16Busulfan 13Antilymphocyte Serum 13Peripheral Blood Stem Cell Transplantation 12Mycophenolic Acid 12Cyclosporine 11Tacrolimus 9Methylprednisolone 8Filgrastim 8Epoetin Alfa 8Cord Blood Stem Cell Transplantation 7Whole-Body Irradiation 6Radiotherapy 6Methotrexate 6Melphalan 5Etoposide 4Darbepoetin alfa 4Cytarabine 4fludarabine 3Therapeutics 2Immunoenzyme Techniques 2Granulocyte Colony-Stimulating Factor 2Carmustine 2tipifarnib 1sargramostim 1ferrous sulfate 1ferric gluconate 1epoetin beta 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × Microarray Analysis × Classical hematology × Clear all
NCT00900055 2022-07-05

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

OHSU Knight Cancer Institute

Completed
213 enrolled
Classical hematologyMyeloidPlasma cell

Fanconi Anemia, Multiple Myeloma, Myeloproliferative Disorders, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡